Patents by Inventor James Anderson-Furgeson

James Anderson-Furgeson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230235398
    Abstract: A method for determining a subject's risk for developing chronic kidney disease (CKD) combined with determining a subject's pharmacogenomic (PGX) profile is described. The method involves obtaining a sample of genetic material from the subject. The genetic material is amplified using primers specific for the genes underlying CKD and PGX. The DNA sequence of the amplified genetic material is determined and compared with the human reference genome sequence. One or more DNA sequence alterations in the amplified genetic material not present in the human reference genome sequence determines the PGX profile of the subject and may indicate that the subject is at risk for developing CKD.
    Type: Application
    Filed: July 26, 2022
    Publication date: July 27, 2023
    Applicant: Machaon Diagnostics, Inc.
    Inventors: James S. Kain, Ph.D., Michael P. Ero, MT, CLS, MBA, James Anderson-Furgeson, Jihyun Moon